OPKO Health is the most heavily shorted name among its closest peers by a wide margin. Its short interest reached 5.0% of free float as of 20 October. The next most comparable name in its peer group carries a fraction of that positioning. OPK rose 25.8% over the past week. Its closest peers gained a median of 1.2% over the same period. That gap…
OPK upgraded to Outperform by Barrington Research, bouncing 17.5% in one week to $1.61.
Key data as of 5 Nov 2026
OPK upgraded to Outperform by Barrington Research, bouncing 17.5% in one week to $1.61.
OPK cost to borrow surges to 0.94%, up 107% in one week, amid stock rally to $1.61.
Barrington Research reversed its April downgrade on OPK on 16 October, lifting the stock back to Outperform. Piper Sandler moved on the same day, raising its price target from $3.00 to $4.00 while reiterating…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OPK — free to start on ORTEX.
Sign up for free →Open OPK on ORTEX